Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature

Authors:

Open Access

8 November 2005

journal article
review article
Published by Public Library of Science (PLoS) in PLOS Medicine

Vol. 2 (12) , e392
DOI:10.1371/journal.pmed.0020392
PMID:16268734
PMCID:PMC1277931

Abstract

Many ads for SSRI antidepressants claim that the drugs boost brain serotonin levels. Lacasse and Leo argue there is little scientific evidence to support this claim.

Keywords

This publication has 24 references indexed in Scilit:

Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Cochrane Database of Systematic Reviews, 2006
Is mood chemistry?
Nature Reviews Neuroscience, 2005
Toward a Philosophical Structure for Psychiatry
American Journal of Psychiatry, 2005
Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine
BMJ, 2005
Active placebos versus antidepressants for depression
Cochrane Database of Systematic Reviews, 2004
Direct-To-Consumer Marketing of Prescription Drugs
CNS Drugs, 2004
Direct to consumer advertising is medicalising normal human experienceFor
BMJ, 2002
The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in Humans
Pharmacopsychiatry, 1996
Amine Precursors and Depression
Archives of General Psychiatry, 1975
The Biochemistry of Affective Disorders
The British Journal of Psychiatry, 1967